Llwytho...
Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin
BACKGROUND: Azithromycin (AZI) is recommended with Ceftriaxone (CRO) for treatment of uncomplicated gonococcal urethritis and cervicitis in the United States (US) and an AZI susceptibility breakpoint is needed. Neither the FDA (Food and Drug Administration) nor the CLSI (Clinical and Laboratory Stan...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Infect Dis |
|---|---|
| Prif Awduron: | , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785360/ https://ncbi.nlm.nih.gov/pubmed/30963175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz292 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|